Recent national patterns of warfarin use in atrial fibrillation

Circulation

Volumn 97, Issue 13, 1998, Pages 1231-1233

  Stafford, Randall S ^a,c   Singer, Daniel E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE   (United States)

Author keywords

Anticoagulants; Atrial fibrillation; Physician practice patterns

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; AORTA THROMBOSIS; ARTICLE; CLINICAL PRACTICE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STROKE;

EID: 0032492737     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.13.1231     Document Type: Article

References (22)

1. Atrial Fibrillation Investigators. Atrial fibrillation: risk factors for embolization and efficacy of antithrombotic therapy. Arch Intern Med. 1994;154:1449-1457.
2. Lackner TE, Battis GN. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients. Arch Fam Med. 1995;4:1017-1026.
3. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avron J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med. 1997;157:978-984.
4. Antani MR, Beyth RJ, Covinsky KE, Anderson PA, Miller DG, Cebul RD, Quinn LM, Landefeld CS. Failure to prescribe warfarin to patients with nonrheumatic alrial fibrillation. J Gen Intern Med. 1996;11:713-720.
5. Whittle J, Wickenheiser L, Vendittii LN. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med. 1997;157:441-445.
6. Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med. 1996;156:2311-2316.
7. Stafford RS, Singer DE. Warfarin use in atrial fibrillation by U. S. physicians. Arch Intern Med. 1996;156:2537-2541.
8. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ. 1997;314:1529-1530.
9. National Center for Health Statistics. Public Use Data Tape Documentation: 1989-1996 National Ambulatory Medical Cure Survey. Hyattsville, MD: National Center for Health Statistics, US Public Health Service. 1991-1998.
10. Potthoff RF, Woodbury MA, Manton KG. 'Equivalent sample size' and 'equivalent degrees of freedom' refinements for inference using survey weights under superpopulation models. J Am Stat Assoc. 1992;87:383-396.
11. National Center for Health Statistics. International Classification of Diseases, 9th Revision, Clinical Modification. 3rd ed, vol 1. Washington, DC: US Public Health Service: 1989. DHHS publication (PHS) 89-1260.
12. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108(suppl): 352S-359S.
13. Statistical Analysis System. SAS/STAT User's Guide, Version 6. 4th ed, vol 1 and 2. Cary, NC: Statistical Analysis System; 1990:851, 1072.
14. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley; 1989.
15. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
16. Petersen P, Godtfredsen J, Boysen G, Andersen ED, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet. 1989;1:175-179.
17. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991;84:527-539.
18. Connolly SJ, Laupacis A, Gent M, Roberts RS, Carins JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18:349-355.
19. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtake JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992;327:1406-1412.
20. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1256-1262.
21. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomized trials. Arch Intern Med. 1997;157:1237-1240.
22. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med. 1994;154:1945-1953.